112418-54-9

Basic information

• Product Name: (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE
• Synonyms: (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE
• CAS NO: 112418-54-9
• Molecular Formula: C₁₁H₁₇NO
• Molecular Weight: 179.26
• Mol File: 112418-54-9.mol

Chemical Properties

• Boiling Point: 287.7±13.0 °C(Predicted)
• Appearance: /
• Density: 0.984±0.06 g/cm3(Predicted)
• PKA: 5.24±0.10(Predicted)
• CAS DataBase Reference: (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE(112418-54-9)
• EPA Substance Registry System: (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE(112418-54-9)

Safety Data

• Hazardous Substances Data: 112418-54-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE is used as a synthetic intermediate for the development of various pharmaceuticals. Its unique structure allows it to be a key component in the creation of new drugs, potentially contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
In the field of organic chemistry, (S)-4-(2-METHYL-BUTOXY)-PHENYLAMINE serves as a versatile building block for the synthesis of a range of organic compounds. Its reactivity and functional groups enable it to participate in various chemical reactions, facilitating the production of complex molecules for different applications.

Upstream product

• 100-02-7 4-nitro-phenol 
• 534-00-9 (S)-2-methylbutyl bromide 
• 1991-59-9 (S)-(+)-4-(2-methyl-1-butoxy)nitrobenzene 
• 38261-81-3 (S)-2-methylbutyl tosylate 

Downstream Products

• 325770-74-9 (S)-N-[4-(2-methylbutyloxy)phenyl]-2,3,4-tris(hexyloxy)-benzalimine 
• 1127647-81-7 C₃₇H₄₉NO₅ 
• 1127647-82-8 C₃₉H₅₃NO₅ 
• 1127647-83-9 C₄₁H₅₇NO₅ 
• 1127647-77-1 C₃₁H₃₇NO₅ 
• 1127647-78-2 C₃₂H₃₉NO₅ 
• 1127647-79-3 C₃₃H₄₁NO₅ 
• 1127647-80-6 C₃₅H₄₅NO₅ 
• 1127647-74-8 C₂₈H₃₁NO₅ 
• 1127647-75-9 C₂₉H₃₃NO₅ 
• 1127647-76-0 C₃₀H₃₅NO₅ 

Relevant articles and documents

Effect of fluorocarbon chains on the mesomorphic properties of chiral imines and their complexes with copper(II)

The synthesis and mesomorphism of new chiral imine compounds incorporating a fluorocarbon chain which have calamitic molecular shape and their complexes with copper(II) are reported. The liquid crystalline properties were investigated using polarised optical microscopy, differential scanning calorimetry and X-ray diffraction. Imine compounds with a semifluorinated chain and a short chiral chain show chiral smectic mesophases with dramatically enhanced mesophase stabilities compared to the related hydrocarbon derivatives. In addition, the first examples of mesogenic chiral salicylaldiminate copper(II) complexes carrying semifluorinated alkyl chains at their peripheries have been synthesized and their liquid crystalline properties were investigated.

Disc-like chiral palladium and platinum complexes: Synthesis and mesomorphic properties

ortho-Palladated and -platinated benzalimines are a widely studied novel type of liquid-crystals. These sheet-shaped materials contain two or even four metal atoms and carry eight and twelve flexible side-chains, respectively. Here we present the preparation and mesomorphic properties of dinuclear chiral homologues of such sheet-like compounds. On their own, the chiral members of the dinuclear cyclopalladated series exhibit no liquid-crystalline properties, but show mesophase inductions (Colh-phase) in mixtures with an electron-acceptor, e.g.,2,4,7-trinitroflourenone (TNF). A diplatinated chiral analogue, however, monotropically exhibits the cholesteric nematic discotic (ND/*) type of mesophase. Mixtures of this platinum nematogen with TNF also show the induction of a columnar mesophase (Colh) due to charge-transfer interactions.

The Preparation and Thermal Properties of Terminal Disubstituted N-(4-Benzoyloxybenzylidene)anilines

The homologous series of N--4-(2-methylbutoxy)aniline (1), and N-benzylidene>-4-n-alkoxyaniline (2), and N--4-(2-methylbutoxy)aniline (3) where the 2-methylbutoxyl group has an S-configuration, have been prepared.Series 1 and 2 form a chiral smectic C (S*C) phase in addition to a cholesteric (Ch) and a chiral smectic G (S*G) phases, and series 3 form (S*C) and Ch phases.